Brief: Io Biotech Provides Business Update

IO Biotech

09/01/2023 13:31

Jan 9 (Reuters) - IO Biotech Inc  IOBT.O :
    * IO BIOTECH PROVIDES BUSINESS UPDATE
    * IO BIOTECH INC- ENDED 2022 WITH APPROXIMATELY $142.7
MILLION IN
CASH AND CASH, ANTICIPATES THIS WILL BE SUFFICIENT TO FUND
OPERATIONS INTO MID-2024
    * IO BIOTECH- ENCOURAGING INITIAL DATA FROM 9 PATIENTS FROM
PHASE
2 SOLID TUMOR BASKET TRIAL EVALUATING IO102-IO103 IN COMBINATION
WITH PEMBROLIZUMAB
    * IO BIOTECH INC- SAFETY PROFILE OBSERVED TO DATE IN  PHASE
2
SOLID TUMOR BASKET STUDY IS CONSISTENT WITH PRIOR CLINICAL
EXPERIENCE WITH IO102-IO103

Source text for Eikon:  ID:nGNX1THqVJ 
Further company coverage:  IOBT.O 
 ((Reuters.Briefs@thomsonreuters.com;))